The history of vaccine and vaccination against influenza in Poland

被引:0
作者
Brydak, Lidia B. [1 ,2 ,3 ]
Grypy, Kierownik Zakladu Badania Wirusow [1 ]
机构
[1] Państwowy Inst Badawczy, Narodowy Inst Zdrow Publicznego PZH, Warsaw, Poland
[2] Panstwowy Inst Badawczy, Narodowy Inst Zdrowia Publicznego PZH, Zakladu Badania Wirusow Grypy, Ul Chocimska 24, PL-00791 Warsaw, Poland
[3] Panstwowy Inst Badawczy, Narodowy Inst Zdrowia Publicznego PZH, Krajowego Osrodka Grypy, Ul Chocimska 24, PL-00791 Warsaw, Poland
来源
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE | 2023年 / 19卷 / 03期
关键词
influenza; vaccine; humoral response; pharmacoeconomics; CORONARY-ARTERY-DISEASE; IMMUNE-RESPONSE; KINETICS; CHILDREN;
D O I
10.15557/PiMR.2023.0032
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The influenza virus is an important cause of morbidity, complications and mortality worldwide. Anyone can be infected, regardless of latitude or age. The paper describes the history of obtaining a modern influenza vaccine that does not deviate from current World Health Organization standards in Poland. Dozens of studies assessing the post-vaccination humoral response for different types of influenza vaccine, measuring levels of anti-haemagglutinin and anti-neuraminidase antibodies (although not in all of the studies) have been presented. The research was conducted mainly in high-risk populations, regardless of the age of vaccine recipients. What is noteworthy, the paper presents specific examples that may help promote prevention and encourage healthcare personnel to protect not only patients, but also their relatives. Prophylaxis in the form of vaccination is the cheapest and most effective form of preventing both dangerous complications and mortality. Infection caused by the influenza virus should be viewed not only in the context of exacerbation of a pre-existing disease or causing a new disease, but also in terms of measurable public costs. There are many types of imported influenza vaccines available on the Polish pharmaceutical market, from the inactivated intramuscular split or subunit vaccine to the intranasal live vaccine obtained from strains adapted to lower replication temperatures. Currently, quadrivalent influenza vaccines, i.e. containing two influenza A virus subtypes (A/H1N1/pdm09, A/H3N2) and two influenza B virus lineages (Victoria and Yamagata), are used. Depending on the type of vaccine, immunisation is recommended from the age of 6 months, whereas the upper age limit is not specified. The composition of vaccines is updated every epidemic season.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [21] Epitope-based vaccine against influenza
    Ben-Yedidia, Tamar
    Arnon, Ruth
    EXPERT REVIEW OF VACCINES, 2007, 6 (06) : 939 - 948
  • [22] Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules
    Grodeland, Gunnveig
    Bogen, Bjarne
    EXPERT REVIEW OF VACCINES, 2015, 14 (06) : 805 - 814
  • [23] The clinical predictors of and vaccine protection against severe influenza infection in children
    Tsai, Chu-Fei
    Liu, Yun-Chung
    Chang, Tu-Hsuan
    Wu, En-Ting
    Chang, Luan-Yin
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (03)
  • [24] Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended
    Fogel, Benjamin
    Hicks, Steven
    VACCINE, 2017, 35 (39) : 5278 - 5282
  • [25] Midwives influenza vaccine uptake and their views on vaccination of pregnant women
    Ishola, D. A., Jr.
    Permalloo, N.
    Cordery, R. J.
    Anderson, S. R.
    JOURNAL OF PUBLIC HEALTH, 2013, 35 (04) : 570 - 577
  • [26] Influenza Vaccination Coverage, Motivators for, and Barriers to Influenza Vaccination among Healthcare Workers in Wroclaw, Poland
    Jedrzejek, Michal Jacek
    Mastalerz-Migas, Agnieszka
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [27] The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History
    Moritzky, Savannah A.
    Richards, Katherine A.
    Glover, Maryah A.
    Krammer, Florian
    Chaves, Francisco A.
    Topham, David J.
    Branche, Angela
    Nayak, Jennifer L.
    Sant, Andrea J.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (03) : 381 - 390
  • [28] Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany
    Scholz, Stefan M.
    Weidemann, Felix
    Damm, Oliver
    Ultsch, Bernhard
    Greiner, Wolfgang
    Wichmann, Ole
    VALUE IN HEALTH, 2021, 24 (01) : 32 - 40
  • [29] Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population
    Reber, Adrian J.
    Chirkova, Tatiana
    Kim, Jin Hyang
    Cao, Weiping
    Biber, Renata
    Shay, David K.
    Sambhara, Suryaprakash
    AGING AND DISEASE, 2012, 3 (01): : 68 - 90
  • [30] VACCINATION AGAINST INFLUENZA IN NURSING-HOMES IN BRUSSELS
    DEWALS, P
    DAUFFENBACH, S
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1992, 40 (05): : 355 - 364